| Primary |
| Product Used For Unknown Indication |
42.8% |
| Drug Use For Unknown Indication |
29.9% |
| Suicide Attempt |
11.1% |
| Pain |
2.5% |
| Pyrexia |
2.4% |
| Nasopharyngitis |
1.5% |
| Headache |
1.3% |
| Ill-defined Disorder |
1.0% |
| Intentional Overdose |
0.9% |
| Hypertension |
0.9% |
| Back Pain |
0.8% |
| Arthralgia |
0.7% |
| Anaesthesia |
0.7% |
| Analgesic Therapy |
0.6% |
| Procedural Pain |
0.6% |
| Depression |
0.6% |
| Completed Suicide |
0.5% |
| Drug Exposure During Pregnancy |
0.5% |
| Osteoarthritis |
0.4% |
| Overdose |
0.4% |
|
| Completed Suicide |
19.2% |
| Intentional Overdose |
12.0% |
| Toxicity To Various Agents |
11.8% |
| Overdose |
10.9% |
| Drug Toxicity |
10.2% |
| Intentional Drug Misuse |
5.4% |
| Vomiting |
4.9% |
| Death |
3.9% |
| Acute Hepatic Failure |
2.6% |
| Suicide Attempt |
2.6% |
| Liver Injury |
2.5% |
| Medication Error |
2.5% |
| Cardio-respiratory Arrest |
1.7% |
| Hepatic Failure |
1.7% |
| Drug Abuse |
1.6% |
| Renal Failure Acute |
1.5% |
| Transaminases Increased |
1.4% |
| Metabolic Acidosis |
1.3% |
| Accidental Overdose |
1.2% |
| Multiple Drug Overdose Intentional |
1.2% |
|
| Secondary |
| Product Used For Unknown Indication |
40.4% |
| Drug Use For Unknown Indication |
27.1% |
| Suicide Attempt |
6.6% |
| Pain |
5.4% |
| Pyrexia |
3.7% |
| Ill-defined Disorder |
2.1% |
| Hypertension |
1.9% |
| Headache |
1.5% |
| Foetal Exposure During Pregnancy |
1.3% |
| Nasopharyngitis |
1.3% |
| Depression |
1.1% |
| Prophylaxis |
1.1% |
| Analgesic Therapy |
1.0% |
| Back Pain |
0.9% |
| Arthralgia |
0.8% |
| Drug Exposure During Pregnancy |
0.7% |
| Rheumatoid Arthritis |
0.7% |
| Asthma |
0.7% |
| Intentional Overdose |
0.7% |
| Migraine |
0.7% |
|
| Completed Suicide |
15.5% |
| Toxicity To Various Agents |
14.8% |
| Drug Toxicity |
13.5% |
| Overdose |
9.4% |
| Death |
5.8% |
| Vomiting |
4.9% |
| Intentional Drug Misuse |
4.2% |
| Suicide Attempt |
4.2% |
| Respiratory Arrest |
3.8% |
| Intentional Overdose |
3.4% |
| Toxic Epidermal Necrolysis |
3.1% |
| Poisoning |
2.5% |
| Multiple Drug Overdose |
2.2% |
| Renal Failure Acute |
2.1% |
| Acute Hepatic Failure |
2.0% |
| Multiple Drug Overdose Intentional |
1.8% |
| Hepatic Failure |
1.8% |
| Liver Injury |
1.8% |
| Cardio-respiratory Arrest |
1.7% |
| Somnolence |
1.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.8% |
| Drug Use For Unknown Indication |
16.3% |
| Pain |
8.1% |
| Prophylaxis |
5.5% |
| Rheumatoid Arthritis |
5.2% |
| Premedication |
5.1% |
| Hypertension |
4.7% |
| Crohn's Disease |
2.4% |
| Depression |
2.0% |
| Multiple Myeloma |
2.0% |
| Constipation |
1.9% |
| Nausea |
1.8% |
| Headache |
1.7% |
| Hepatitis C |
1.5% |
| Diabetes Mellitus |
1.5% |
| Pyrexia |
1.4% |
| Insomnia |
1.4% |
| Osteoporosis |
1.4% |
| Anxiety |
1.3% |
| Asthma |
1.1% |
|
| Vomiting |
15.3% |
| Pyrexia |
7.7% |
| Weight Decreased |
6.7% |
| Thrombocytopenia |
5.9% |
| Pneumonia |
5.5% |
| Pulmonary Embolism |
5.5% |
| Pain |
5.2% |
| Death |
4.8% |
| Urinary Tract Infection |
4.7% |
| Renal Failure Acute |
4.4% |
| Sepsis |
4.3% |
| White Blood Cell Count Decreased |
4.1% |
| Nausea |
3.9% |
| Rash |
3.5% |
| Weight Increased |
3.4% |
| Renal Failure |
3.3% |
| Myocardial Infarction |
3.1% |
| Headache |
3.0% |
| Dyspnoea |
3.0% |
| Diarrhoea |
2.8% |
|
| Interacting |
| Product Used For Unknown Indication |
54.3% |
| Pyrexia |
5.5% |
| Pain |
4.9% |
| Ill-defined Disorder |
3.6% |
| Back Pain |
3.2% |
| Metastatic Malignant Melanoma |
3.2% |
| Drug Use For Unknown Indication |
3.0% |
| Arthralgia |
2.7% |
| Lymphadenopathy |
2.7% |
| Hypertension |
2.4% |
| Atrial Fibrillation |
2.2% |
| Gastroenteritis |
2.0% |
| Influenza Like Illness |
2.0% |
| Headache |
1.3% |
| Prophylaxis |
1.3% |
| Constipation |
1.2% |
| Neuralgia |
1.2% |
| Suicide Attempt |
1.1% |
| Arthritis |
1.0% |
| Lobar Pneumonia |
1.0% |
|
| Drug Interaction |
21.9% |
| Cholestasis |
15.3% |
| Hypothermia |
8.0% |
| Pyrexia |
8.0% |
| International Normalised Ratio Increased |
6.6% |
| Haematoma |
4.4% |
| Anticoagulation Drug Level Above Therapeutic |
3.6% |
| Haemorrhage |
3.6% |
| Overdose |
2.9% |
| Sepsis |
2.9% |
| Transaminases Increased |
2.9% |
| Blood Alkaline Phosphatase Increased |
2.2% |
| Dermatitis Exfoliative |
2.2% |
| Encephalopathy |
2.2% |
| Haematuria |
2.2% |
| Headache |
2.2% |
| Metabolic Acidosis |
2.2% |
| Pneumonia |
2.2% |
| Prothrombin Time Prolonged |
2.2% |
| Pyroglutamate Increased |
2.2% |
|
